COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 2890: Articles 28891-28900  | Next

Lies, Gosh Darn Lies, and Not Enough Good Statistics: Why Epidemic Model Parameter Estimation Fails
Platt, D. E., Parida, L. E., Zalloua, P.
10.1101/2020.04.20.20071928 — Posted: 2020-04-21
Effects of medical resource capacities and intensities of public mitigation measures on outcomes of COVID-19 outbreaks
Wang, X., Li, Q., Sun, X., He, S., Xia, F., Song, P., Shao, Y., Wu, J., Cheke, R. A., Tang, S., Xiao, Y.
10.1101/2020.04.17.20070318 — Posted: 2020-04-21
COVID-19 Epidemic Dynamics and Population Projections from Early Days of Case Reporting in a 40 million population from Southern India
Pant, R., Choudhry, L. P., Rajesh, J. G., Yeldandi, V. V.
10.1101/2020.04.17.20070292 — Posted: 2020-04-21
Estimating the probability of New Zealand regions being free from COVID-19 using a stochastic SEIR model
Bogacz, R.
10.1101/2020.04.20.20073304 — Posted: 2020-04-21
COVID-19 Critical Illness Pathophysiology Driven by Diffuse Pulmonary Thrombi and Pulmonary Endothelial Dysfunction Responsive to Thrombolysis
Poor, H. D., Ventetuolo, C. E., Tolbert, T., Chun, G., Serrao, G., Zeidman, A., Dangayach, N. S., Olin, J., Kohli-Seth, R., Powell, C. A.
10.1101/2020.04.17.20057125 — Posted: 2020-04-21 Discussion: Onsite
Differential ventilation using flow control valves as a potential bridge to full ventilatory support during the COVID-19 crisis
Levin, M., Chen, M. D., Shah, A., Shah, R., Zhou, G., Kane, E., Burnett, G., Ranginwala, S., Madek, J., Gidiscin, C., Park, C., Katz, D., Salter, B., Kohli-Seth, R., Eisenkraft, J. B., Uysal, S., McCarry, M., Leibowitz, A. B., Reich, D. L.
10.1101/2020.04.14.20053587 — Posted: 2020-04-21
COVID-19-Associated Acute Disseminated Encephalomyelitis: A Case Report
Zhang, T., Rodricks, M. B., Hirsh, E.
10.1101/2020.04.16.20068148 — Posted: 2020-04-21 Discussion: Offsite
Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection
Bernard-Valnet, R., Pizzarotti, B., Anichini, A., Demars, Y., Russo, E., Schmidhauser, M., Cerruti-Sola, J., Rossetti, A. O., Du Pasquier, R.
10.1101/2020.04.17.20060251 — Posted: 2020-04-21
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19)
Zhong, M., Sun, A., Xiao, T., Yao, G., Sang, L., Zheng, X., Zhang, J., Jin, X., Xu, L., Yang, W., Wang, P., Hu, K., Zhang, D., Ge, J.
10.1101/2020.04.15.20066266 — Posted: 2020-04-21 Discussion: Onsite
Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections
Bradley, B. T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S. L., Xu, H., Najafian, B., Marshall, D., Lacy, J. M., Williams, T., Yarid, N.
10.1101/2020.04.17.20058545 — Posted: 2020-04-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).